Connie Lebakken,
Chief Operating Officer
Connie Lebakken, Ph.D., Co-founder and Chief Operating Officer of Stem Pharm Incorporated, has extensive experience in cell biology, assay development and advancing technologies through the product development pipeline. She received a Ph.D. in Cellular and Molecular Biology from the University of Wisconsin, and postdoctoral training in Physiology and Biophysics at the University of Iowa. She has held leadership roles in Operations and Research and Development at life science companies throughout her career. Dr. Lebakken has expertise in the development of high-throughput biochemical and cell-based drug discovery assays and in developing tools and protocols to improve stem cell workflows. She is currently leading Stem Pharm’s efforts to commercialize advanced biomaterials for cellular applications including advanced cellular assays, organoid formation for screening purposes and cell expansion for therapeutic purposes.
|
|
|
